TRDA

NASDAQ 已收盘

Entrada Therapeutics

4.64 USD
▼-0.39-7.75%
盘后 4.66 0.00%
2026-11-19
市值
$158.80M
市盈率
—
EPS
-3.84
股息率
—
52 周区间
4.11 – 16.45
成交量
341.09K
Beta
-0.15
目标价
17.75
52W 低 4.1152W 高 16.45
价格走势

公司简介

Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company’s Endosomal Escape Vehicle, therapeutic candidates are based on a novel therapeutic; a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases. Its preclinical product includes ENTR-601-44; ENTR-601-45; and VX-670. The company was f...